Advanced and metastatic prostate cancer is often incurable, but its dependency on certain
molecular alterations may provide the basis for targeted therapies. A growing body of …

Peroxisome proliferator activatedreceptor-gamma (PPARγ) is a memberof the nuclear
receptor superfamily ofligand-activated transcription factors. PPARγ is expressed at high …

The development and maintenance of the prostate are dependent upon a complex series of
interactions occurring between the epithelial and stromal tissues (Hayward and Cunha …

Background Prostate cancer (PC) remains a leading cause of cancer mortality and the most
successful chemopreventative and treatment strategies for PC come from targeting the …

Despite great progress in the detection and treatment of prostate cancer, this disease
remains an incredible health and economic burden. Although androgen receptor (AR) …

Peroxisome proliferator-activated receptor (PPAR) α is a member of the nuclear receptor
superfamily of ligand-activated transcription factors. PPARα is activated by peroxisome …

Peroxisome proliferator-activated receptor-γ (PPAR-γ) is being studied intensively for its role
in carcinogenesis and in mediating the effects of prostate cancer treatment and prevention …

The peroxisome proliferator-activated receptor gamma (PPARγ) is a member of the nuclear
receptor superfamily. Recent studies found that ligand-activated PPARγ regulated …

The peroxisome proliferator‐activated receptor‐gamma (PPARγ) is a member of the
hormone‐activated nuclear receptor superfamily. PPARγ can be activated by a diverse …

Peroxisome proliferator‐activated receptor‐γ (PPAR)‐γ is a ligand‐activated transcriptional
factor belonging to steroid receptor superfamily. PPAR‐γ plays a role in both adipocyte …